PATENT CLAIM ANALYSIS

Application Number: 15967187
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "210000"]

Abstract:
Compounds having a structure of formula (I), including stereoisomers and pharmaceutically acceptable salts and solvates thereof: wherein R 1  is as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, hyperkinetic disorders. Also disclosed are compositions containing these compounds in combination with a pharmaceutically acceptable carrier or diluent, as well as methods relating to the use in a subject in need thereof.

Claim (Index 22):
The method of  claim 21 , wherein the hyperkinetic disorder is Huntington's disease, tardive dyskinesia, Tourette's syndrome or tics.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.37097
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15627145', '15017480', '15116786', '11937445', '13237709']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8241463193366005
- 35 USC 102 Novelty (BERT): 0.5991319443052384
- Combined Prediction Score: 0.8016448818334643
- Mean Citation Score: 422.62164999999993
- Max Citation Score: 558.68744
- Similarity Product: 442.9088592961312

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test